TGTX icon

TG Therapeutics
TGTX

Overview Fund Activity

45 hedge funds and large institutions have $27.7M invested in TG Therapeutics in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-1
Holders Change %
-2.17%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
14
Reduced
11
Closed
13
Calls
$64K
Puts
$91K
Net Calls
-$27K
Net Calls Change
-$27K

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$8.58M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.63M
3
SGAM
3
Smith Group Asset Management
Texas
$767K
4
CCI
4
Columbus Circle Investors
$631K
5
BM
5
Bridger Management
New York
$6.42M

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$1.78M
2
RCM
2
RA Capital Management
Massachusetts
$0
3
Millennium Management
3
Millennium Management
New York
$0
4
SM
4
Sabby Management
Florida
$257K
5
Neuberger Berman Group
5
Neuberger Berman Group
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
51
A.R.T. Advisors
New York
– -$71K -14,268 Closed
BRWA
52
B. Riley Wealth Advisors
Florida
– -$56K -11,194 Closed
RFC
53
Russell Frank Company
Washington
– -$42K -7,025 Closed
TRCT
54
Tower Research Capital (TRC)
New York
– -$15K -3,037 Closed
Ameriprise
55
Ameriprise
Minnesota
– -$5K -967 Closed
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
– -$2K -320 Closed
1 2
3